Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Nina Friesgaard Øbro"'
Autor:
Signe Modvig, Rasmus Wernersson, Nina Friesgaard Øbro, Lars Rønn Olsen, Claus Christensen, Susanne Rosthøj, Matilda Degn, Gitte Wullf Jürgensen, Hans O. Madsen, Birgitte Klug Albertsen, Peder Skov Wehner, Steen Rosthøj, Henrik Lilljebjörn, Thoas Fioretos, Kjeld Schmiegelow, Hanne Vibeke Marquart
Publikováno v:
Molecular Oncology, Vol 16, Iss 10, Pp 2015-2030 (2022)
Minimal residual disease (MRD) constitutes the most important prognostic factor in B‐cell precursor acute lymphoblastic leukemia (BCP‐ALL). Flow cytometry is widely used in MRD assessment, yet little is known regarding the effect of different imm
Externí odkaz:
https://doaj.org/article/41b83b7d35024792a3b3111ab77d73b5
Autor:
Rabiah Fardoos, Claus Christensen, Nina Friesgaard Øbro, Ulrik Malthe Overgaard, Bodil Als-Nielsen, Hans Ole Madsen, Hanne Vibeke Marquart
Publikováno v:
Diagnostics, Vol 13, Iss 21, p 3306 (2023)
Next-generation sequencing (NGS) methods have been introduced for immunoglobulin (IG)/T-cell receptor (TR) gene rearrangement analysis in acute lymphoblastic leukemia (ALL) and lymphoma (LBL). These methods likely constitute faster and more sensitive
Externí odkaz:
https://doaj.org/article/f0b318d72f9a476586eda39b2c094923
Autor:
null Signe Modvig, null Rasmus Wernersson, null Nina Friesgaard Øbro, null Lars Rønn Olsen, null Claus Christensen, null Susanne Rosthøj, null Matilda Degn, null Gitte Wullf Jürgensen, null Hans O Madsen, null Birgitte Klug Albertsen, null Peder Skov Wehner, null Steen Rosthøj, null Henrik Lilljebjörn, null Thoas Fioretos, null Kjeld Schmiegelow, null Hanne Vibeke Marquart
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4c7c0289048ef30e1e2e5ed70753398d
https://doi.org/10.1002/1878-0261.13207/v2/response1
https://doi.org/10.1002/1878-0261.13207/v2/response1
Autor:
Carsten Friis, Kirsten Grønbæk, Linda Jacobsen, Christophe Côme, Klaus T. Jensen, Louise Rosgaard, Anders H. Lund, Cathrine K. Fog, Alison Louw, Fazila Asmar, Arie Koen Braat, Jens Vilstrup Johansen, Maarten van Lohuizen, Kristian Anthonsen, Elisabeth Ralfkiaer, Nina Friesgaard Øbro, Hanne Vibeke Marquart, Tony Bou Kheir
Publikováno v:
Blood. 125:1272-1281
The PR-domain (PRDM) family of genes encodes transcriptional regulators, several of which are deregulated in cancer. By using a functional screening approach, we sought to identify novel tumor suppressors among the PRDMs. Here we demonstrate oncogeni
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::814892d084c3043b1616e6de49dfe3ea
https://doi.org/10.1182/blood-2014-03-560805
https://doi.org/10.1182/blood-2014-03-560805
Autor:
Hanne Vibeke Marquart, L P Ryder, Jon Helgestad, Kjeld Schmiegelow, Peder Skov Wehner, Hans O. Madsen, Birgitte Klug Albertsen, Mette K. Andersen, Nina Friesgaard Øbro, Bjarne Blindbæk Lausen
Publikováno v:
Øbro, N F, Marquart, H V H, Madsen, H O, Ryder, L P, Andersen, M K, Lausen, B B, Albertsen, B K, Skov Wehner, P, Helgestad, J & Schmiegelow, K 2011, ' Immunophenotype-defined sub-populations are common at diagnosis in childhood B-cell precursor acute lymphoblastic leukemia ', Leukemia, vol. 25, no. 10, pp. 1652-7 . https://doi.org/10.1038/leu.2011.136
Obro, N F, Marquart, H V H, Madsen, H O, Ryder, L P, Andersen, M K, Lausen, B B, Albertsen, B K, Wehner, P S, Helgestad, J & Schmiegelow, K 2011, ' Immunophenotype-defined sub-populations are common at diagnosis in childhood B-cell precursor acute lymphoblastic leukemia ', Leukemia, vol. 25, no. 10, pp. 1652-7 . https://doi.org/10.1038/leu.2011.136
Obro, N F, Marquart, H V H, Madsen, H O, Ryder, L P, Andersen, M K, Lausen, B B, Albertsen, B K, Wehner, P S, Helgestad, J & Schmiegelow, K 2011, ' Immunophenotype-defined sub-populations are common at diagnosis in childhood B-cell precursor acute lymphoblastic leukemia ', Leukemia, vol. 25, no. 10, pp. 1652-7 . https://doi.org/10.1038/leu.2011.136
Immunophenotype-defined sub-populations are common at diagnosis in childhood B-cell precursor acute lymphoblastic leukemia
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3ae96363b8d8ebf734f6db3de8834482
https://doi.org/10.1038/leu.2011.136
https://doi.org/10.1038/leu.2011.136
Autor:
Susanne Rosthøj, Gitte W Jürgensen, Nina Friesgaard Øbro, Signe Modvig, Kjeld Schmiegelow, Hanne Vibeke Marquart
Publikováno v:
Blood. 128:1728-1728
Background Flow cytometry is widely used for B-cell precursor acute lymphoblastic leukemia (BCP-ALL) diagnosis, and the detection of Minimal Residual Disease (MRD) by flow cytometry is an established stratification tool after induction therapy. Early
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::03c149c5c42b9c3fb52f5dc2a28e4dd8
https://doi.org/10.1182/blood.v128.22.1728.1728
https://doi.org/10.1182/blood.v128.22.1728.1728
Autor:
Kjeld Schmiegelow, Lars P. Ryder, Hans O. Madsen, Birgitte Lausen, Henrik Hasle, Mette K. Andersen, Hanne Vibeke Marquart, Nina Friesgaard Øbro
Publikováno v:
Obro, N F, Ryder, L P, Madsen, H O, Andersen, M K, Lausen, B, Hasle, H, Schmiegelow, K & Marquart, H V H 2012, ' Identification of residual leukemic cells by flow cytometry in childhood B-cell precursor acute lymphoblastic leukemia: verification of leukemic state by flow-sorting and molecular/cytogenetic methods ', Haematologica, vol. 97, no. 1, pp. 137-41 . https://doi.org/10.3324/haematol.2011.051383
Reduction in minimal residual disease, measured by real-time quantitative PCR or flow cytometry, predicts prognosis in childhood B-cell precursor acute lymphoblastic leukemia. We explored whether cells reported as minimal residual disease by flow cyt
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1974a9824e3599101bed2aa59a452d09
https://pubmed.ncbi.nlm.nih.gov/21933850
https://pubmed.ncbi.nlm.nih.gov/21933850
Autor:
Kjeld Schmiegelow, Hans O. Madsen, Lars P. Ryder, Mette K. Andersen, Nina Friesgaard Øbro, Hanne Vibeke Marquart
Publikováno v:
Journal of immunological methods. 369(1-2)
Discordances between minimal residual disease estimates obtained by different methods are a problem in childhood acute lymphoblastic leukemia. We aimed to optimize methods allowing the biological exploration of such discrepancies, i.e. the combinatio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1c18d2ca3d38ebe6e0522c3073eacbba
https://pubmed.ncbi.nlm.nih.gov/21570982
https://pubmed.ncbi.nlm.nih.gov/21570982
Autor:
Hanne Offenberg, Ulrik Lademann, Nils Brünner, Nina Friesgaard Øbro, Lars Holten-Andersen, Karin Birkenkamp-Demtröder
Publikováno v:
Friesgaard Øbro, N, Lademann, U, Birkenkamp-Demtröder, K, Holten-Andersen, L, Brünner, N & Offenberg, H 2008, ' A TIMP-1 splice variant transcript: Possible role in regulation of TIMP-1 expression ', Cancer Letters, vol. 262, pp. 64-70 . https://doi.org/10.1016/j.canlet.2007.11.030
Udgivelsesdato: 2008 Jan 2 A splice variant of tissue inhibitor of metalloproteinases-1 (TIMP-1) mRNA lacking exon 2 (TIMP-1-v2) has been identified in human cancer cells and in colorectal and breast cancer tumors. The purpose of this study was (1) t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7e13b8e1a36f965d2ca1a19413ba2ad2
https://pubmed.ncbi.nlm.nih.gov/18180096
https://pubmed.ncbi.nlm.nih.gov/18180096
Autor:
Birgitte Klug Albertsen, Nina Toft, Thomas Frandsen, Lars P. Ryder, Peder Skov Wehner, Kjeld Schmiegelow, Nina Friesgaard Øbro, Steen Rosthoej, Hanne Vibeke Marquart, Hans O. Madsen, Mette K. Andersen
Publikováno v:
Øbro, N F, Ryder, L P, Madsen, H O, Andersen, M K, Albertsen, B K, Wehner, P S, Rosthøj, S, Toft, N, Frandsen, T L, Schmiegelow, K & Marquart, H V H 2014, ' Intra-Tumoral Blast Heterogeneity and Implications for Minimal Residual Disease Detection in T-Cell Acute Lymphoblastic Leukemia ', Blood, vol. 124, no. 21, 1076 . < http://www.bloodjournal.org/content/124/21/1076 >
Aarhus University
Øbro, N F, Ryder, L P, Madsen, H O, Andersen, M K, Albertsen, B K, Wehner, P S, Rosthøj, S, Toft, N, Frandsen, T L, Schmiegelow, K & Marquart, H V H 2014, ' Intra-Tumoral Blast Heterogeneity and Implications for Minimal Residual Disease Detection in T-Cell Acute Lymphoblastic Leukemia ', ASH Annual Meeting, San Francisco, United States, 06/12/2014-09/12/2014 . < https://ash.confex.com/ash/2014/webprogram/Paper71334.html >
Friesgaard Øbro, N, Ryder, L P, Madsen, H-O, Andersen, M K, Albertsen, BK, Skov Wehner, P, Rosthøj, S, Toft, N, Frandsen, T L, Schmiegelow, K & Marquart, H V H 2014, ' Intra-Tumoral Blast Heterogeneity and Implications for Minimal Residual Disease Detection in T-Cell Acute Lymphoblastic Leukemia ', ASH 2014 American Society of Hematology, San Francisco, United States, 06/12/2014-09/12/2014 .
Aarhus University
Øbro, N F, Ryder, L P, Madsen, H O, Andersen, M K, Albertsen, B K, Wehner, P S, Rosthøj, S, Toft, N, Frandsen, T L, Schmiegelow, K & Marquart, H V H 2014, ' Intra-Tumoral Blast Heterogeneity and Implications for Minimal Residual Disease Detection in T-Cell Acute Lymphoblastic Leukemia ', ASH Annual Meeting, San Francisco, United States, 06/12/2014-09/12/2014 . < https://ash.confex.com/ash/2014/webprogram/Paper71334.html >
Friesgaard Øbro, N, Ryder, L P, Madsen, H-O, Andersen, M K, Albertsen, BK, Skov Wehner, P, Rosthøj, S, Toft, N, Frandsen, T L, Schmiegelow, K & Marquart, H V H 2014, ' Intra-Tumoral Blast Heterogeneity and Implications for Minimal Residual Disease Detection in T-Cell Acute Lymphoblastic Leukemia ', ASH 2014 American Society of Hematology, San Francisco, United States, 06/12/2014-09/12/2014 .
Introduction:The early treatment response, measured as minimal residual disease (MRD), is the most important tool for treatment stratification in T-cell acute lymphoblastic leukemia (T-ALL). Flow cytometry-based MRD (Flow-MRD) monitoring, in addition
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9bba94a4d76b6970d7f09fa0a1985c78
https://doi.org/10.1182/blood.v124.21.1076.1076
https://doi.org/10.1182/blood.v124.21.1076.1076